EGFR deletion in myeloid cells did not affect OS development in terms of differences in tumor number, burden or serum ALP levels, suggesting that EGFR expression in myeloid cells, which include bone‐resorbing osteoclasts, is dispensable during c‐Fos‐induced OS formation (Appendix Fig S1A–C). This evidence concerns the gene FOS and neoplasm.